Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Wagner

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Sexually Transmitted Diseases|September 16, 2015
Associations of Anogenital Low-Risk Human Papillomavirus Infection With Cancer and Acquisition of HIVLiga E Bennetts, Monika Wagner, Anna R Giuliano, et al.
Cost Effectiveness and Resource Allocation : C/E|July 20, 2012
From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmakingLalla Aïda Guindo, Monika Wagner, Rob Baltussen, et al.
International Journal of Technology Assessment in Health Care|December 3, 2013
Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makersNataly Tanios, Monika Wagner, Michèle Tony, et al.
Scientific Reports|December 7, 2021
Macroclimatic conditions as main drivers for symbiotic association patterns in lecideoid lichens along the Transantarctic Mountains, Ross Sea region, AntarcticaMonika Wagner, Georg Brunauer, Arne C Bathke, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2022
HTA challenges for appraising rare disease interventions viewed through the lens of an institutional multidimensional value frameworkMonika Wagner, Mireille M Goetghebeur, Isabelle Ganache, et al.
International Journal of Technology Assessment in Health Care|October 12, 2017
EXPLORING VALUES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES USING REFLECTIVE MULTICRITERIA AND RARE DISEASE CASEMireille M Goetghebeur, Monika Wagner, Dima Samaha, et al.
International Journal of Health Policy and Management|August 24, 2019
Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case StudyMonika Wagner, Dima Samaha, Roman Casciano, et al.
Advances in Therapy|December 23, 2017
Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United StatesMonika Wagner, Dima Samaha, Hanane Khoury, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way ForwardRob Baltussen, Kevin Marsh, Praveen Thokala, et al.
Psychology & Health|February 20, 2016
Implementation intention and planning interventions in Health Psychology: Recommendations from the Synergy Expert Group for research and practiceMartin S Hagger, Aleksandra Luszczynska, John de Wit, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Sexually Transmitted Diseases|September 16, 2015
Associations of Anogenital Low-Risk Human Papillomavirus Infection With Cancer and Acquisition of HIVLiga E Bennetts, Monika Wagner, Anna R Giuliano, et al.
Cost Effectiveness and Resource Allocation : C/E|July 20, 2012
From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmakingLalla Aïda Guindo, Monika Wagner, Rob Baltussen, et al.
International Journal of Technology Assessment in Health Care|December 3, 2013
Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makersNataly Tanios, Monika Wagner, Michèle Tony, et al.
Scientific Reports|December 7, 2021
Macroclimatic conditions as main drivers for symbiotic association patterns in lecideoid lichens along the Transantarctic Mountains, Ross Sea region, AntarcticaMonika Wagner, Georg Brunauer, Arne C Bathke, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2022
HTA challenges for appraising rare disease interventions viewed through the lens of an institutional multidimensional value frameworkMonika Wagner, Mireille M Goetghebeur, Isabelle Ganache, et al.
International Journal of Technology Assessment in Health Care|October 12, 2017
EXPLORING VALUES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES USING REFLECTIVE MULTICRITERIA AND RARE DISEASE CASEMireille M Goetghebeur, Monika Wagner, Dima Samaha, et al.
International Journal of Health Policy and Management|August 24, 2019
Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case StudyMonika Wagner, Dima Samaha, Roman Casciano, et al.
Advances in Therapy|December 23, 2017
Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United StatesMonika Wagner, Dima Samaha, Hanane Khoury, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way ForwardRob Baltussen, Kevin Marsh, Praveen Thokala, et al.
Psychology & Health|February 20, 2016
Implementation intention and planning interventions in Health Psychology: Recommendations from the Synergy Expert Group for research and practiceMartin S Hagger, Aleksandra Luszczynska, John de Wit, et al.
Pageof 4